Equillium (NASDAQ: EQ) shares plummeted 38% from $1.38 to 86 cents Thursday after the company said collaboration partner Ono Pharmaceutical let lapse its option to acquire Equilliums rights to itolizumab, a monoclonal antibody targeting the CD6-ALCAM signaling pathway, which plays a key role in modulating effector T cells that drive numerous immuno-inflammatory diseases
The researchers note that GLP-1 drugs offer protection by reducing harmful brain proteins, inflammation, and insulin resistance
David Hunter, MD, an associate professor of neurology at UTHealth Houston, not involved in this review, spoke with Medical News Today about its findings
Dissolve 1 oral strip above or under your tongue as needed
BMC Public Health (2009) 9:88
this combination has been shown to decrease appetite, blood glucose, and hunger in the hours following a meal with 2-3 eggs